Hindsight Media
Subscribe

Johnson & JohnsonJNJ

HealthcareNYSEFinancial year ends in January

Makes prescription medicines, including cancer and immunology drugs, and medical devices for surgery, orthopaedics and heart care.

Filings to the SEC

FilingPeriodFiled
Quarterly report 10-Q27 September 202621 October 2026
Announcement 8-K: Results13 October 2026
Announcement 8-K: Directors or officers4 August 2026
Announcement 8-K: Regulation FD disclosure29 July 2026
Announcement 8-K: Regulation FD disclosure28 July 2026
Quarterly report 10-Q28 June 202623 July 2026
Announcement 8-K: Results15 July 2026
Announcement 8-K: Shareholder vote28 April 2026
Quarterly report 10-Q29 March 202622 April 2026
Announcement 8-K: Results, Other events14 April 2026
Annual report 10-K28 December 202511 February 2026
Announcement 8-K: Results21 January 2026
Quarterly report 10-Q28 September 202522 October 2025
Announcement 8-K: Results, Other events14 October 2025
Announcement 8-K: Directors or officers9 September 2025
Quarterly report 10-Q29 June 202524 July 2025
Announcement 8-K: Results16 July 2025
Announcement 8-K: Directors or officers10 June 2025
Announcement 8-K: Directors or officers, Shareholder vote30 April 2025
Quarterly report 10-Q30 March 202523 April 2025
Announcement 8-K: Results, Other events15 April 2025
Announcement 8-K: Regulation FD disclosure3 April 2025
Announcement 8-K: Other events26 February 2025
Announcement 8-K: Other events20 February 2025
Annual report 10-K29 December 202413 February 2025
Announcement 8-K: Results22 January 2025
Quarterly report 10-Q29 September 202423 October 2024
Announcement 8-K: Results15 October 2024
Announcement 8-K: Regulation FD disclosure20 September 2024
Announcement 8-K: Directors or officers10 September 2024
Announcement 8-K: Directors or officers26 August 2024
Quarterly report 10-Q30 June 202425 July 2024
Announcement 8-K: Results17 July 2024
Announcement 8-K: Other events20 May 2024
Announcement 8-K: Other events17 May 2024
Quarterly report 10-Q31 March 20241 May 2024
Announcement 8-K: Results, Regulation FD disclosure1 May 2024
Announcement 8-K: Articles or bylaws, Shareholder vote29 April 2024
Announcement 8-K: Results, Other events16 April 2024
Annual report 10-K31 December 202316 February 2024

The most recent 40. Every filing is on the SEC’s website.

Charts and live prices are delayed, from TradingView. Market values use each company’s last trade on IEX at the previous close, times the shares in issue from its filings; company figures come from SEC filings. This is information, not investment advice. Where our market data comes from

Company logos are trademarks of their owners, shown only to identify them; the files are from Wikimedia Commons.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.